Abstracts tagged "diagnosis and fibromyalgia"

Abstract Number: 1988 • 2017 ACR/ARHP Annual Meeting
Most Fibromyalgia Patients in a Rheumatology Office Practice Accept the Diagnosis of Fibromyalgia
Robert S. Katz¹, Jessica L. Polyak² and Frank Leavitt¹, ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: In the community, many comments are made about fibromyalgia that are not accurate, such as, it is a made-up illness; a ‘garbage’ diagnosis; everything…
Abstract Number: 38 • 2016 ACR/ARHP Annual Meeting
How Does Thiol/Disulphide Homeostasis Change in Fibromyalgia Patients?
Bilge Ekinci¹, Cemile Bicer², Pervin Baran³, Sema Haliloglu⁴, Hulya Uzkeser⁵ and Ayse Carlioglu⁶, ¹Physical Medicine and Rehabilitation, Erzurum Region Training and Research Hospital, Erzurum, Turkey, ²Biochemistry, Yildirim Beyazit University Medical Faculty, Ankara, Turkey, ³Biochemistry, Ataturk Training and Research Hospital, Ankara, Turkey, ⁴Physical Medicine and Rehabilitation, Maltepe Occupational Diseases Hospital, Istanbul, Turkey, ⁵Physical Medicine and Rehabilitation, Ataturk University Medical Faculty, erzuru, Turkey, ⁶Endocrinology, Erzurum Region Training and Research Hospital, Erzurum, Turkey
Background/Purpose: Our aim was to investigate the thiol/disulphide homeostasis, which has an important role in many cellular activities such as antioxidant protection, detoxification, cell growth…
Abstract Number: 2223 • 2016 ACR/ARHP Annual Meeting
Can Fibromyalgia be Empirically Defined By the Number of Pain Locations Plus Symptoms?
Robert M. Bennett¹, Kim D. Jones¹, Jonathan H. Aebischer² and Amanda W. St. John³, ¹Schools of Nursing and Medicine, Oregon Health & Science University, Portland, OR, ²Department of Family Medicine, Oregon Health & Science University, Portland, OR, ³Anesthesiology and Pain Medicine, Oregon Health & Science University, Portland, OR
Background/Purpose: Both the revised 2010 FM criteria (Wolfe et al.) and the 2013 FM criteria (Bennett et al.), rely on counting the number of pain…
Abstract Number: 913 • 2015 ACR/ARHP Annual Meeting
A Comparison of Physician Based and Patient Based Criteria for the Diagnosis of Fibromyalgia
Frederick Wolfe¹, Mary-Ann Fitzcharles², Don Goldenberg³, Winfried Häuser⁴, Robert S. Katz⁵, Philip J. Mease⁶, Anthony Russell⁷, Jon Russell⁸ and Brian Walitt⁹, ¹National Data Bank, Wichita, KS, ²MGH, Montreal, QC, Canada, ³Newton-Wellesley Hospital, Newton, MA, ⁴Department of Psychosomatic Medicine and Psychotherapy, Technische Universität München, Munich, Germany, ⁵Rush University Medical Center, Chicago, IL, ⁶Department of Rheumatology, Swedish Medical Center and University of Washington, Seattle, WA, ⁷Medicine, University of Alberta, Edmonton, AB, Canada, ⁸Fibromyalgia Research and Consulting, San Antonio, TX, ⁹National Institutes of Health, National Institute of Nursing Research, Bethesda, DC
Background/Purpose: The American College of Rheumatology (ACR) 2010 preliminary criteria for the diagnosis of fibromyalgia requires ascertainment of pain extent and symptoms by physicians. The…
Abstract Number: 2076 • 2014 ACR/ARHP Annual Meeting
Predictive Modeling of a Fibromyalgia Diagnosis: Increasing the Accuracy Using Real World Data
Birol Emir¹, Jack Mardekian¹, Elizabeth T. Masters¹, Andrew Clair¹, Max Kuhn² and Stuart L. Silverman³, ¹Pfizer Inc, New York, NY, ²Pfizer Inc., Groton, CT, ³Cedars-Sinai Medical Center, UCLA Center of Excellence, Los Angeles, CA
Background/Purpose: The number of symptoms and comorbidities associated with the chronic pain condition of fibromyalgia (FM) complicates its identification and diagnosis. Methods: This retrospective analysis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].